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Mucus hypersecretion is characteristic of chronic airway diseases. However, regulatory mechanisms are
poorly understood. Human airway epithelial cells grown on permeable supports at the air–liquid interface
 




. Such cultures provide a model for
studying secretory cell lineage, differentiation, and function, and may provide insight regarding events
leading to mucus hypersecretion. The mucin gene expression profile of well-differentiated human airway
epithelial cells in culture has not yet been established. We compared expression of all the currently de-
scribed mucin genes in poorly differentiated (conventional cultures on plastic) and well-differentiated (ALI)
human nasal and bronchial epithelial cells. Differentiation-dependent upregulation of MUC3, MUC5AC,
MUC5B, and MUC6 messenger RNA (mRNA) was demonstrated using reverse transcriptase–polymerase
chain reaction (RT–PCR). Northern blot analysis showed a similar increase for MUC4 and demonstrated
that induction of MUC4 and MUC5B expression depended on retinoic acid. MUC1, MUC2, MUC7, and
MUC8 mRNAs were also detected by RT–PCR, but these genes did not appear to be strongly regulated as
a function of differentiation. Mucin gene expression was similar in bronchial and nasal cells. Thus, muco-




 entails upregulation of several mucin genes.
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An overlying mucous layer protects the airway epithelium
and traps particulates for mucociliary clearance. This layer
is composed primarily of large, gel-forming, oligomeric
mucin glycoproteins that are produced by both airway sur-
face goblet cells and submucosal gland mucous cells. In
chronic airway diseases such as asthma, chronic bronchitis,
and cystic fibrosis, submucosal glands become enlarged
(hypertrophy), the number of goblet cells in the airway
surface epithelium increases (hyperplasia), and goblet cells
appear in distal airways where they are not normally
present (metaplasia). As part of the overall disease pro-
cess, these cellular changes often result in mucus hyperse-
cretion and/or the production of mucus with altered physi-
cal properties, which in turn may increase resistance to air




 1, 2, and refer-
ences therein). In certain cases, the resulting physiologic
airway obstruction may lead to chronic infection. A more
thorough understanding of mucin gene expression may
permit the development of novel therapeutic approaches
for treating chronic airway diseases.
To date, nine mucin genes have been identified in hu-
mans. Four of these, MUC2, MUC5AC, MUC5B, and
MUC6, are clustered at chromosomal location 11p15.5
and are structurally related (3). The complete complemen-
tary DNA (cDNA) sequence and at least partial genomic
structure have been determined for the membrane-bound
mucin MUC1 (4, 5), the intestinal mucin MUC2 (6–8), and
the small salivary mucin MUC7 (9, 10).
MUC4 (11), MUC5AC (12, 13), MUC5B (14), and
MUC8 (15) were originally cloned from airway epithelial
cDNA libraries. MUC1, MUC2, MUC3, MUC6, and
MUC7 are also expressed in airway epithelia (16–20), al-
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and stomach, respectively, are probably present at very
low levels.
The predominant mucins in adult respiratory secretions
appear to be MUC5AC and MUC5B (21–24). MUC2 is
expressed in airway epithelial cells and appears to be regu-
lated by various factors in culture (25–27) and in certain
disease states (7, 28); however, it may be a minor compo-
nent of airway epithelial secretions in most cases (22).
MUC4 is also expressed in airway and may contribute to
respiratory secretions. The tissue distribution of the MUC4
messenger RNA (mRNA) has been well characterized
(18, 29, 30), but the MUC4 gene is known only by a 48-
base-pair (bp) repeat sequence (11), and the biochemical
nature of the gene product is poorly understood.
Recent technical advances now permit the routine pro-
duction of human airway epithelial cell cultures with a mu-





These culture techniques, together with improved trans-
fection protocols, will facilitate the study of mucosecretory
cell differentiation and the control of mucin gene expres-
sion. The tissue dissociation process yields primary cells
derived principally from the airway surface as opposed to
the submucosal glands, and an important consideration is
how the cultures compare with the known expression in
native adult epithelia, both at the level of gene expression
and in the composition of the secreted proteins. A funda-
mental step in this direction is to define patterns of expres-





In the current study, we evaluated gene expression for
MUC1–MUC8. We compared mucus-secreting cultures
grown on permeable supports at the air–liquid interface
(ALI) with cultures grown submerged on tissue-culture
plastic and determined the expression patterns of the
known mucin genes. The submerged cultures exhibit a rel-
atively uniform morphology when compared with the mu-
cociliary phenotype seen both in native tissues and in cul-
tures grown at the ALI, and are used as examples of un- or
predifferentiated airway epithelial cells. We also com-
pared nasal and tracheobronchial cell cultures. We report
for the first time the differentiation- and retinoic acid (RA)–
dependent expression of MUC4, normally expressed in
both bronchi and bronchioles, and MUC5B, a submucosal






Well-differentiated cultures from passage 1 (p1) or pas-
sage 2 (p2) airway epithelial cells were grown using proce-
dures modified as follows from those described by Gray
and colleagues (31). Normal lung and nasal tissues were
obtained from patients undergoing thoracic surgery or
elective nasal surgical procedures as per Institutional Re-
view Board–approved protocols. Excised airways, from
which excess connective tissue had been removed, were
rinsed in cold Joklik’s minimum essential medium plus an-
tibiotics and then incubated in 0.1% protease (Sigma Type




C (32–34). Ten percent serum was
added to neutralize the protease, and cells were freed by
gentle scraping and agitation. The cells were washed, re-










 cells/100-mm-diameter collagen-coated tissue-cul-
ture dish in modified LHC9 medium (35), termed bron-
chial epithelial growth medium (BEGM). The modifica-
tions included increasing the epidermal growth factor
(EGF) concentration to 25 ng/ml, adjusting the RA con-










 M and the gentamicin concentra-




g/ml, and adding 0.5 mg/ml bovine serum al-














amphotericin. Collagen-coated dishes were prepared by









100 (Collagen Biomaterials, Palo Alto, CA) in distilled









face area. The Vitrogen solution was then aspirated, and
the dishes were dried and sterilized for 10 min under ultra-
violet (UV) light. At approximately 75% confluence, the
cells were harvested by trypsinization and subpassaged at












 on 24-mm Transwell-
COL inserts (T-COL; Costar, Cambridge, MA) in ALI me-
dium. ALI is similar to BEGM except that a 50:50 mixture
of LHC Basal and Dulbecco’s modified Eagle’s medium-
H is used as the base, amphotericin and gentamicin are
omitted, and the EGF concentration is reduced to 0.5 ng/
ml. Upon reaching confluence (3 to 7 d), the apical surface
was rinsed with phosphate-buffered saline, and medium
was replaced only in the bottom compartment of the cul-
ture. When standard tissue-culture wells (2 ml/well) were
used, medium was changed daily; in some cases Deep Well
Plates (12 ml/well; Becton Dickinson, Franklin Lakes, NJ)
were used and medium was changed twice weekly. For
studies of mucin gene expression, RNA was isolated from
both near confluent primary cells on plastic and from well-
differentiated p1 or p2 cells grown on T-COL membranes




For histologic evaluation, specimens were prepared using




) fixation with 2% formaldehyde–
2% glutaraldehyde and embedding in glycol methacrylate













 dissolved in perfluorocarbon (37)
followed by direct immersion in 100% ethanol, conven-
tional embedding in epon/araldite resin, and preparation




m-thick sections. Richardson’s stain was




Total RNA was isolated from cultured cells using TRI Re-
agent (Molecular Research Center, Inc., Cincinnati, OH)
according to the manufacturer’s instructions. Because of
the high mucin content of some samples, we included the
optional steps suggested for samples with high carbohy-
drate levels, and this was found to increase RNA yield and
purity. RNA was quantitated spectrophotometrically.
 
Polymerase Chain Reaction Template Preparation
 
RNA samples were digested with RQ1 ribonuclease
(RNase)-free deoxyribonuclease (DNase) in the presence
of RNasin RNase inhibitor (both from Promega, Madison,





digested material was purified with an RNeasy Mini Prep
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kit (Qiagen, Chatsworth, CA) using the protocol titled
“RNA Cleanup” in the product manual. Integrity of the





preparation on an ethidium bromide (EBr)–containing
agarose gel and visualizing the ribosomal RNA bands with
a UV transilluminator.
RNA prepared as described previously was reverse
transcribed using Random Primer oligonucleotides and




 Reverse Transcriptase (both
from GIBCO BRL, Grand Island, NY) as per the manu-
facturer’s instructions. To reduce variability between poly-
merase chain reaction (PCR) reactions, enough first-strand
cDNA was made at one time to provide template for all
PCR amplifications. PCR conditions were optimized em-
pirically using AmpliTaq Gold DNA polymerase (Perkin–
Elmer, Branchburg, NJ) and a PTC-100 thermal cycler
(MJ Research, Inc., Watertown, MA). PCR analysis of the










1). For each primer pair, the identity of the PCR product
was confirmed by digesting with a specific restriction en-
donuclease to give products of predicted sizes.
For each tissue type and culture condition (bronchial
plastic, bronchial T-COL, nasal plastic, nasal T-COL),
RNA was pooled from different individuals (4, 12, 4, and 6
cultures, respectively; equal quantities of RNA from each
culture), for a total of four pools. (RNA from these same









mize experimental error, all pools were handled identi-
cally and processed at the same time. For a given mucin
primer pair, all four template pools were amplified simul-
taneously. Negative controls, consisting of reaction mix-
tures containing all components except template, were in-




The primers used are listed in Figure 1. Primers for
MUC1, MUC2 and MUC5AC, and MUC7 were from ref-
erences (38), (39), and (9), respectively. All other primers
were designed using GCG Wisconsin Package Software




The linear range of the amplification was determined by
sampling the PCR reactions every three cycles, starting at
cycle 15 to 21 and continuing through cycle 39. PCR reac-
tions were run on NuSeive agarose gels (FMC BioProd-
ucts, Rockland, ME), and the gels were stained with EBr.
Digitized images of the gels were obtained using an Image-
Store 7500 Gel Documentation System (UVP, Upland,
CA) and were analyzed using the public-domain program
NIH Image. To compensate for possible irregularity in UV
illumination and charged coupled device (CCD) camera
sensitivity, gels were positioned consistently on the UV
light box before imaging. Once the linear range was deter-
mined for a given primer pair, the PCR reactions were run
twice more for the appropriate number of cycles. Band in-
tensity varied considerably between the different primer
pairs and slightly from run to run for the same primer pair
(probably due to variations in EBr staining). Band inten-
sity was normalized for each of the three runs by setting
the average intensity of the bands from the four different
template pools to “1” and adjusting the values for the
bands accordingly. Normalized values from the three runs
were averaged, and the standard deviation was calculated
as a measure of experimental error. The average values
were then standardized with respect to the cyclophilin









Northern analysis was performed according to standard
procedures as outlined (40). For the airway epithelial cell
lanes, RNA from multiple cultures was pooled (the same
RNA preparations used for PCR analysis). Dermal fibro-
blast RNA was prepared from cultures of human foreskin
fibroblasts. RNA from trachea, intestine, and salivary
gland was obtained from Clontech (Palo Alto, CA). After
denaturing agarose gel electrophoresis on a 1.2% gel,




 by capillary transfer.
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and riboprobe for MUC4 (Riboprobe Gemini System;









547-bp fragment of NP3a (12) (kindly provided by Dr.
Mary Rose, Children’s Hospital Medical Center, Washing-
ton, DC). For detection of MUC5B mRNA, a PCR prod-
uct from the carboxy terminus of MUC5B (Accession no.
S80993, bases 74-586) was TA cloned into the pCRII-TOPO
vector (Invitrogen, Carlsbad, CA). Identity and integrity
of the cloned fragment were confirmed by DNA sequenc-
ing. The MUC4 probe consisted of 75 bases from the tandem
repeat region of the MUC4 gene (Accession no. M64594,
bases 111–184) cloned into pBluescript as previously de-
scribed (18). After hybridization, blots were exposed to




Recent technical improvements permit the reproducible
production of well-differentiated human airway epithelial
cell cultures. Dissociated cells are seeded on T-COL mem-
branes and grow to confluence within 3 to 7 d. After con-
fluence, no bulk leakage of medium from the basolateral
to the apical surface of the epithelium occurs, and the cells
grow at an ALI. By 14 d after confluence, extensive ciliary
beating is apparent and collections of mucoid material are





21 d), cells typical of native epithelium, including cili-
ated, basal, and secretory cells, are apparent (Figure 3).
Well-differentiated cultures often persist for more than
2 mo, but pores eventually form in the epithelia and dis-
rupt barrier function. Primary airway epithelial cells cul-
tured on plastic assume a mostly uniform morphology
without recognizable ciliated or secretory cells.
PCR was used to screen nasal and bronchial cell cul-
tures for expression of all described mucins except for the
predominantly airway epithelial mucin MUC4 (41), which
was screened by Northern blot. For MUC4, the only pub-
lished nucleotide sequence is from the repetitive region of
the gene, which is unsuitable for the design of PCR prim-
ers (11).
For comparative PCR, in which expression levels of a
single gene are compared between samples, PCR time
courses were generated for all primer pairs to determine
the linear range of the PCR reactions. The time courses
for the 11p15 cluster mucins, MUC2, MUC5AC, MUC5B,
and MUC6, and the standard, cyclophilin, are shown in
Figure 2. These time courses illustrate the expected in-
crease in PCR product quantity.
Cyclophilin was chosen as an internal standard to cor-
rect for variations in the starting concentrations of tem-
plate cDNA. Cyclophilin is a cytosolic protein that binds
cyclosporin A, and it also may be involved in protein fold-
ing. It is abundant in eukaryotic cells, and the level ap-
pears stable in most tissues and cell lines (42). The levels
of cyclophilin mRNA in airway epithelial cells appear to
remain constant under conditions that affect the level of
MUC2 expression (7).
Bar graphs comparing expression levels for mucin
genes in nasal and bronchial cultures grown on tissue-cul-
ture plastic and on T-COL membranes are shown in Fig-
ure 4. Of the primary secreted respiratory mucins, MUC5AC
and MUC5B show differentiation-dependent changes in
expression, with the level increasing in the T-COL cul-
tures. MUC3 and MUC6 also show this pattern. MUC5B
and MUC3 show the most dramatic increases, with ap-
proximately 4-fold more signal in T-COL cultures as com-
pared with plastic. MUC1 and MUC7 may have slight
increases in expression in T-COL cultures. The level of
MUC2 remains fairly constant. For all mucin genes, simi-
lar patterns of expression were found in bronchial and na-
sal epithelial cell cultures.
Northern blot analysis was used to determine the ex-
pression pattern for MUC4, and to confirm expression of
the important airway mucins MUC5AC and MUC5B. All
three of these mucins were detected in nasal and bronchial
cells grown on T-COL membranes, but not in those grown
on plastic (Figure 5). The high molecular-weight smear
seen for these mucins is typical for RNA prepared by con-
ventional methods. Debailleul and associates (43) have
demonstrated that this polydispersity is most likely due to
mechanical shearing of the very large mRNA transcripts
(up to 24 kb), rather than to physiologic mechanisms or
nuclease degradation. This would explain the difference in
molecular-weight profile seen between the MUC4 and
MUC5B signals in Figures 5 and 6, because the RNA
preps used in Figure 6 were handled considerably more
than those in Figure 5. The commercially prepared tra-
cheal RNA also shows more smearing than the RNA pre-
pared from cell cultures in Figure 5, and this is probably
due to differences in preparative technique. As expected
Figure 2. Differentiation-depen-
dent expression of 11p15.5 clus-
ter mucins for bronchial and na-
sal cells grown on plastic (Pl)
and T-COL membranes (T), as
determined by reverse transcrip-
tase (RT)–PCR. Order of panels
depicts the gene order on the
chromosome. PCR product band
intensity in EBr-stained agarose
gels shows the linear range of
the reactions for MUC6, MUC2, MUC5AC, MUC5B, and the internal standard, cyclophilin. The cycle numbers (indicated near top of
figure) used for triplicate determinations are circled. RT–PCR assays for MUC1, MUC3, MUC7, and MUC8 were analyzed the same
way (gels not shown).
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from the established tissue distribution, MUC4, MUC5AC,
and MUC5B were strongly expressed in human trachea,
and were not detected in dermal fibroblasts or intestine.
The time course of MUC4 and MUC5B expression and
the RA dependence are shown in Figure 6. Six days after
plating on T-COL membranes, no MUC5B was detected.
By 13 d, MUC5B was expressed in the presence of RA.
For MUC4, high molecular-weight transcripts also appear
by 13 d. The significance of the low molecular-weight
smear in the 6-d sample is not clear. Examination of the ri-
bosomal RNA bands indicate that the 6-d RNA sample is
not more degraded than samples at the later time points.
The band across all lanes at approximately 4.4 kb corre-
sponds in position and intensity to the large ribosomal
subunit, and probably represents nonspecific binding of the
probe. In the absence of RA, both MUC4 and MUC5B
expression were completely suppressed. Figure 7 shows
the morphology of the cultures from 6 to 27 d in the pres-
ence and absence of RA. Omission of RA results in loss of





In the normal human airway, mucus glycoproteins are pro-
duced by goblet cells in the surface epithelium and by mu-
cous cells in the submucosal glands. This study is an initial
characterization of mucin gene expression patterns in cul-
tures of human airway epithelial cells that in many ways
resemble native epithelia. Such primary cell cultures will
facilitate the study of mucin gene expression because they




 situation than do most es-
tablished cell lines. Expression of the MUC2 gene, for ex-
ample, appears to be at least an order of magnitude lower
in some cell lines than in native tissue (8). Our ultimate
goal is to use these cultures for transfections and other ma-
nipulations to study airway epithelial cell differentiation
and the regulation of mucin gene expression, protein syn-
thesis and glycosylation, and secretion.
Transcripts from all mucin genes tested—MUC1, MUC2,
MUC3, MUC5AC, MUC5B, MUC6, MUC7, and MUC8—
were detected by PCR in airway cultures, and MUC4 was
detected by Northern blot. The respiratory mucins MUC4,
MUC5AC, and MUC5B were upregulated in differenti-
ated cultures, whereas MUC2 was not. MUC3 and MUC6,
although not considered important respiratory mucins,
were also upregulated upon differentiation. Expression
patterns for the mucin genes were similar in bronchial and
nasal cultures. The upregulation of MUC4 and MUC5B
mRNA expression was shown by Northern blot to depend
on RA.
All of these mucins have been previously described in
the airway (15, 16, 18, 44, 45, 47). MUC3, a predominantly
intestinal mucin, was not detected by Northern blot in cul-





normal airway (18); however, it is detectable by antibodies
in lung tissue (47) and has been shown to be upregulated
in lung adenocarcinoma (19). MUC6 is primarily ex-
pressed in the stomach, gallbladder, and intestine, and al-
though it is not detectable by Northern blot in airway,
faint staining of the tracheal surface epithelium (but not
submucosal glands) has been seen with anti-MUC6 anti-
bodies (20, 48).
Comparing actual abundance of the different mucin
Figure 3. Human airway epi-
thelial cells in vitro. On tissue-
culture plastic, passage 1 bron-
chial (A) and nasal (C) cells (5 d
after seeding) assume a poorly
differentiated morphology. At
an ALI on T-COL membranes,
bronchial (B) and nasal (D) cells
(. 21 d after seeding) exhibit
the well-organized, ciliated, pseu-
dostratified phenotype charac-
teristic of native airway epithelia
containing ciliated, secretory,
and basal cells. The T-COL
membranes are visible below the
cells. Cells grown on plastic were
viewed unfixed by phase micros-
copy. T-COL cultures were fixed
with OsO4-PFC and processed
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mRNAs is problematic with either PCR or Northern blot
techniques because of inherent differences in binding of
primers and probes and to the highly complex structures
of the mucin genes. Our PCR method was not designed to
compare the levels of gene expression of different genes, but
rather to compare the expression of a particular gene in dif-
ferent types of cultures. MUC7 and MUC8 are probably
expressed at very low levels, as PCR gave faint bands at 39
cycles for these genes. The MUC7 and MUC8 primers gave
strong signals with RNA from salivary gland and the lung
carcinoma cell line NCI-H292, respectively (not shown),
suggesting that the primers are reasonably efficient.
These types of assays measure only steady-state levels





 RNA synthesis. The half-lives of MUC2-6 mRNAs
have been shown to be well in excess of 12 h in some cell
lines (8, 43), and it is possible that mucin mRNAs synthe-
sized prior to reestablishment of the mucociliary pheno-
type persist in some cultures. Endotoxin contamination of
the medium is also a potential problem. Endotoxin upreg-
ulates the MUC2 gene (7), and any dependence of expres-
sion on differentiation could be masked if MUC2 has al-
ready been induced.
Experimental variability is a common concern when
PCR is used to obtain quantitative results. Factors such as
reagent variability, inconsistent block temperature, and pi-
petting errors can contribute to experimental error. In this
study, the results of three independent runs were averaged
for each primer pair. The standard deviations for these av-
erages were small, indicating that experimental error was
not a major problem in these reactions. The higher vari-
ability in the MUC7 and MUC8 samples was due to the
low intensity of the PCR product bands.
MUC5AC and MUC5B appear to be the primary com-
ponents of adult airway secretions (21–24). Airway mucus
is secreted by both the goblet cells of the surface epithe-
lium and the mucous cells of the submucosal glands. Gob-
let cells and mucous cells are antigenically distinct (13),
and some of the differences may be due to differential ex-
pression of mucin genes. MUC5AC is predominantly ex-
pressed in surface goblet cells and in some gland neck
cells, and MUC5B is expressed by the mucous cells of the
glands and in bronchioles (16, 49). Although MUC4 is ex-
pressed in airway epithelia, its contribution to airway
secretions has not been determined. MUC4 is circumstan-
tially linked to secretions of the transformed human tra-
cheal gland cell line MM-39, which expresses the MUC4
gene and secretes mucin-like material but does not express
MUC2, MUC3, MUC5AC, or MUC5B. However, these
cells are cultured on tissue-culture plastic and do not ex-
hibit a well-differentiated morphology (50).
The method we used to isolate primary cells probably
yields predominantly surface rather than gland epithelial
cells, so the high level of MUC5B expression suggests
changes in gene expression as the epithelium becomes re-
established in culture. Airway epithelial cells are known to
have great phenotypic plasticity. For example, serous cells
may differentiate into mucosecretory cells after injury,
which the dissociation process may mimic (51). During de-
velopment, MUC5B mRNA is expressed in both surface
tracheal epithelium and developing submucosal glands
at 13 wk of gestation, but by 23 wk it is more prominent
in the glands (18). In the adult, MUC5B is expressed in
the mucous tubules of the submucosal glands (16) and
MUC5AC remains confined to the surface goblet cells





Figure 4. Effect of culture condi-
tions on mucin gene expression in
human airway epithelial cells. Bar
graphs illustrate PCR results, ana-
lyzed as described in MATERIALS
AND METHODS. Units on the y-axis
represent standardized relative in-
tensity (see MATERIALS AND METH-
ODS). Error bars indicate standard
deviation for three separate PCR
runs of the same pooled sample
and represent experimental error.
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basal cells act as gland progenitors and equivalent cells
may be present in the dissociated cell preparation used to





 patterns of gene expression may not be present, or
may be spatially and/or temporally disrupted in the T-COL
culture system. Airway epithelial cell cultures may re-
semble an embryonic stage in which both MUC5B and
MUC5AC are co-expressed, may mimic the healing pro-





. An intermediate phenotype for airway cell
cultures has been described by Sommerhoff and Fink-
beiner (52), who report that proteins characteristic of ei-
ther serous or mucous cells are co-expressed in individual
cells in cultures from tracheal glands. Further studies are
needed to determine whether MUC5AC and MUC5B are
in the same or different cells in the T-COL cultures.
RA is required for mucociliary differentiation and for





retinoid deficiency leads to loss of the normal phenotype
and development of squamous metaplasia (reviewed in
53). Previous studies in cultured human bronchial epi-
thelial cells have demonstrated that RA is necessary for
mucociliary differentiation and for the expression of
MUC5AC and MUC2 (25, 31, 39). The results obtained in
the current study for MUC4 and MUC5B are in agree-
ment with the established role of RA in these cells.
Although MUC3 and MUC6 are unlikely to be major
secreted mucins in airway epithelial cell cultures, their dif-
ferentiation-dependent expression is nevertheless intrigu-
Figure 6. Time course and RA dependence of MUC4 and
MUC5B expression in human bronchial cells. Total RNA was
isolated from cells grown on T-COL membranes or plastic in the
presence (1RA) or absence (2RA) of 5 3 1028 M RA, and ana-
lyzed by Northern blot. Approximately 5 mg RNA was loaded
per 3-mm lane. Lower panel shows ribosomal RNA bands in gel,
visualized with EBr.
Figure 5. Differentiation dependence of MUC4, MUC5AC, and
MUC5B gene expression. Northern blot was probed for MUC4,
MUC5AC, and MUC5B. Total RNA, 20 mg, was loaded per 7-mm
lane. Random-prime labeled MUC5AC and MUC5B cDNA
probes were hybridized overnight at 658C, and the final wash was
at 658C in 0.13 standard saline citrate (SSC). MUC4 riboprobe
was hybridized for 4 h at 708C, and the final wash was at 708C in
0.13 SSC. The same blot was stripped and reprobed for each
gene analyzed. Complete removal of signal was verified after
each hybridization. Lower panel shows ribosomal RNA bands in
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ing. MUC6 is clustered with MUC2, MUC5AC, and
MUC5B (in that order) at chromosomal location 11p15.5
(3). All of these mucin genes except MUC2 show differen-
tiation-dependent regulation in airway epithelial cell cul-
tures. Regulation of this gene cluster is clearly complex, as





. However, the expression pattern in airway
cultures suggests the possibility of some co-regulatory fea-
tures for the 11p15.5 mucin gene cluster. This type of regu-
lation is also seen for MUC3 (7q22) (54, 55) and MUC4
(3q29) (11, 56) but is not pronounced for MUC1, MUC7,
or MUC8, which map to 1q21, 4q13-q21, and 12q24.3, re-
spectively (9, 15, 44). MUC3 and MUC4 may also share
some regulatory elements, even though their tissue distri-
butions are different.
This study presents an expression profile for mucin
genes in well-differentiated cultures of airway epithelial
cells. Companion studies to determine the molecular com-
position of the secreted mucous layer in these cells are cur-
rently in progress. The model provided by these cultures
will complement other experimental systems, for example,




 developmental models, to
further the scope of our knowledge of cell lineage and
gene regulation in the airway epithelium. A greater under-
standing of transcriptional regulation of mucin genes will
provide insights into the pathologic processes characteris-
Figure 7. Effect of RA on morphology of bronchial epithelial cells on T-COL membranes. Cells were grown in the presence (A–C) or
absence (D–F) of RA for 6 (A and D), 13 (B and E), and 27 (C and F) d. In the presence of RA, the well-organized, pseudostratified ep-
ithelial morphology is gradually reestablished, including ciliated and secretory cells. In the absence of RA, the cells form a multilayered,
stratified epithelium resembling keratinocytes. Cultures were fixed with 2% formaldehyde and 2% glutaraldehyde and processed as de-
scribed in MATERIALS AND METHODS.
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tic of chronic airway diseases, and may suggest avenues for
therapeutic interventions.
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